Enitociclib

Enitociclib

Enitociclib

Chemical compound


Enitociclib is an experimental drug that is being investigated for the treatment of cancer.[1] It is an inhibitor of the kinase CDK9.[2][3]

Quick Facts Identifiers, CAS Number ...

References

  1. "Enitociclib - Vincerx Pharma". AdisInsight. Springer Nature Switzerland AG.
  2. Frigault MM, Mithal A, Wong H, Stelte-Ludwig B, Mandava V, Huang X, et al. (November 2023). "Enitociclib, a Selective CDK9 Inhibitor, Induces Complete Regression of MYC+ Lymphoma by Downregulation of RNA Polymerase II Mediated Transcription". Cancer Research Communications. 3 (11): 2268–2279. doi:10.1158/2767-9764.CRC-23-0219. PMC 10634346. PMID 37882668.

Share this article:

This article uses material from the Wikipedia article Enitociclib, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.